Larson Financial Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36
| Closed | -$141 | – | 1928 |
|
|
2023
Q3 | $141 | Hold |
36
| – | – | ﹤0.01% | 1646 |
|
|
2023
Q2 | $117 | Sell |
36
-1
| -3% | -$3 | ﹤0.01% | 1512 |
|
|
2023
Q1 | $134 | Hold |
37
| – | – | ﹤0.01% | 1483 |
|
|
2022
Q4 | $1.19K | Hold |
37
| – | – | ﹤0.01% | 1264 |
|
|
2022
Q3 | $2K | Hold |
37
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q2 | $2K | Hold |
37
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q1 | $3K | Sell |
37
-257
| -87% | -$20.8K | ﹤0.01% | 886 |
|
|
2021
Q4 | $36K | Sell |
294
-1,191
| -80% | -$146K | 0.01% | 445 |
|
|
2021
Q3 | $209K | Sell |
1,485
-83
| -5% | -$11.7K | 0.04% | 144 |
|
|
2021
Q2 | $431K | Buy |
1,568
+6
| +0.4% | +$1.65K | 0.1% | 79 |
|
|
2021
Q1 | $334K | Buy |
1,562
+144
| +10% | +$30.8K | 0.1% | 77 |
|
|
2020
Q4 | $343K | Buy |
1,418
+295
| +26% | +$71.4K | 0.12% | 71 |
|
|
2020
Q3 | $118K | Buy |
1,123
+121
| +12% | +$12.7K | 0.05% | 119 |
|
|
2020
Q2 | $98K | Hold |
1,002
| – | – | 0.05% | 137 |
|
|
2020
Q1 | $75K | Buy |
1,002
+639
| +176% | +$47.8K | 0.05% | 131 |
|
|
2019
Q4 | $30K | Hold |
363
| – | – | 0.02% | 190 |
|
|
2019
Q3 | $44K | Hold |
363
| – | – | 0.03% | 158 |
|
|
2019
Q2 | $65K | Hold |
363
| – | – | 0.05% | 104 |
|
|
2019
Q1 | $58K | Buy |
363
+82
| +29% | +$13.1K | 0.05% | 108 |
|
|
2018
Q4 | $73K | Buy |
+281
| New | +$73K | 0.07% | 90 |
|